- Daaweyn
- Markhaatiyada
- Neuroblastoma
- Buro adag
- Markhaatiyada
- TILS
- Daaweynta Unugyada NK
- Myasthenia Gravis (MG)
- Leukemia-da Lymphoblastic ee Ba'an (B-ALL)
- Lupus Erythematosus oo nidaamsan (SLE)
- Leukemia-da Lymphoblastic ee Ba'an (T-ALL)
- Lymphoma-ka aan Hodgkin ahayn (NHL)
- Myeloma badan (MM)
- Lymphom-ka Unugga B-B ee Kala-baxa
- Leukemia-da B-lymphocytic
- Myeloma
Myasthenia gravis-02
Sheekada Daaweynta Myasthenia Gravis ee Li Ming
Li Ming, oo ah macallin 35 jir ah, ayaa bilaabay inuu dareemo astaamaha myasthenia gravis (MG) saddex sano ka hor. Markii hore, wuxuu arkay ptosis (indhaha oo qalloocan) iyo dhibaato hadal, laakiin calaamadaha ayaa si tartiib tartiib ah u gudbay iyagoo gaaray daciifnimo guud oo muruqa ah, taasoo ka dhigtay xitaa hawlaha maalinlaha ah kuwo adag. In kasta oo uu qaatay daaweyn kala duwan, oo ay ku jiraan steroids iyo daawooyinka difaaca jirka hoos u dhiga, haddana astaamihiisa lama xakamayn.
Iyada oo loo marayo hordhac saaxiib, Li Ming wuxuu yimid BIOOCUS Medical Group si uu uga qaybqaato tijaabo caafimaad oo CAR-T ah. Koox khubaro ah ayaa sameeyay qiimeyn faahfaahsan oo ku saabsan astaamihiisa waxayna u diyaariyeen daaweynta CAR-T.
Habka Daaweynta:
1. Marxaladda Diyaarinta: Kahor daaweynta, Li Ming wuxuu maray qiimeyn caafimaad oo dhammaystiran. Dhakhaatiirtu waxay ka sooceen unugyada T-ga jirkiisa waxayna hidde ahaan wax uga beddeleen shaybaarka si ay u muujiyaan soo-dhoweeyayaasha antigen-ka ee chimeric (CAR) oo bartilmaameedsanaya antigen-yada gaarka ah ee la xiriira myasthenia gravis.
2. Ballaarinta Unugyada: Unugyada CAR-T ee wax laga beddelay ayaa lagu ballaariyay shaybaarka si loo hubiyo tiro ku filan oo loogu talagalay daaweynta.
3. Daaweynta Kiimikada Hore: Kahor inta aan la gelin unugyada CAR-T, Li Ming wuxuu maray daaweyn kiimoterabi ah oo muddo toddobaad ah socotay si loo yareeyo tirada lymphocytes-ka jirkiisa ku jira, taasoo abuurtay jawi ka wanaagsan unugyada CAR-T si ay si wax ku ool ah u shaqeeyaan.
4. Ku-shubista Unugyada CAR-T: Ka dib markii uu dhammeeyay kiimoterabiga, Li Ming ayaa la dhigay isbitaalka si loogu qaado ku-shubista unugga CAR-T. Hawshan waxaa lagu sameeyay kormeer adag si looga hortago waxyeellooyinka iman kara.
Natiijooyinka Daaweynta:
1. Jawaabta Muddada Gaaban: Toddobaadkii ugu horreeyay ka dib markii la geliyay daawada, Li Ming wuxuu la kulmay qandho iyo daal fudud, falcelinno waqti-gaaban ah oo caadi ah oo ku saabsan daaweynta unugyada CAR-T. Laba toddobaad ka dib, ptosis-kiisa iyo dhibka hadalka ayaa si weyn u soo hagaagay, xooggiisuna wuxuu bilaabay inuu soo laabto.
2. Horumarka Muddada Dhexe: Laba bilood ka dib, calaamadaha Li Ming si weyn ayay u yaraayeen. Wuxuu awooday inuu dib u bilaabo hawlihii caadiga ahaa ee waxbaridda, hufnaantiisa shaqo way soo hagaagtay, tayada noloshiisana waxay muujisay horumar weyn.
3. Saamaynta Muddada Dheer: Saddex bilood ka dib daawaynta, Li Ming ma uusan ku tiirsanayn daawooyinkii hore. Baaritaannada daba-galka ah ayaa muujiyay in hab-dhiska difaaca jirkiisu uu xaalad wanaagsan ku jiro, iyadoo aan la arag waxyeellooyin daran.
Iyada oo loo marayo daaweynta unugyada CAR-T, myasthenia gravis ee Li Ming si weyn ayaa loo xakameeyay. "Runtii aad ayaan ugu mahadcelinayaa daaweynta CAR-T iyo kooxda caafimaadka ee heeganka ah dadaalkooda," Li Ming ayaa si ilmada leh u yiri, isagoo gacan qaadaya dhakhtarka markii laga saaray isbitaalka.
sharraxaad2
Submit An Free Inquiry
Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

